DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for DBV Technologies S.A. (DBVT)
« Back to company indexDBVT Chatter Timeline
Stock Ticker for DBVT
Most Active Tweeters for DBVT
| User | Tweets |
|---|---|
| @ConsumerFeed | 2 |
| @AmericanBanking | 2 |
| @SwingTradeBot | 2 |
| @portefeuillefun | 1 |
| @OlympiaReport | 1 |
Recent Tweets for DBVT
 |
@firsttomarkets DBV Technologies SA Initiated Coverage by Goldman Sachs (Ranked 28th) to Buy $DBVT #DBVT https://t.co/cKF5snpPEF June 17th 2019, 11:06am |
 |
@christrade10 RT @psk2329: $DBVT Goldman Sachs analyst Craig Suvannavejh started w/Buy rating and $14 price target. DBVT is a late-stage specialty biotec… June 17th 2019, 8:06am |
 |
@psk2329 $DBVT Goldman Sachs analyst Craig Suvannavejh started w/Buy rating and $14 price target. DBVT is a late-stage speci… https://t.co/FApYfBAUzZ June 17th 2019, 8:06am |
 |
@OlympiaReport DBV TECHNOLOGIE/S $DBVT Rating Lowered to Sell at BidaskClub https://t.co/fGeLAef0km June 17th 2019, 5:06am |
 |
@SwingTradeBot Recent $DBVT technical alerts: Lower Bollinger Band Walk plus 3 more alerts... https://t.co/jBMxhHFfB3 June 16th 2019, 1:06pm |
 |
@dispatchtribune DBV TECHNOLOGIE/S $DBVT Stock Rating Upgraded by Zacks Investment Research https://t.co/6nwPkiDIgn June 14th 2019, 2:06am |
 |
@storminvestor Zacks Investment Research Upgrades DBV TECHNOLOGIE/S $DBVT to Buy https://t.co/2WyQqghRCP #markets June 12th 2019, 10:06pm |
 |
@SleekMoneycom Zacks Investment Research Upgrades DBV TECHNOLOGIE/S $DBVT to Buy https://t.co/4vdatgeIDf #investing June 12th 2019, 10:06pm |
 |
@stocknewstimes Zacks Investment Research Upgrades DBV TECHNOLOGIE/S $DBVT to Buy https://t.co/8AeLd0d5w8 June 12th 2019, 10:06pm |
 |
@SwingTradeIdeas $DBVT - DBV Technologies S.A. (DBVT) Moves to Buy: Rationale Behind the Upgrade https://t.co/YMjHW04up0 June 12th 2019, 10:06am |
 |
@WatchlistN DBV TECHNOLOGIE/S $DBVT Given Consensus Recommendation of “Hold” by Analysts https://t.co/FcAjQqPURp June 11th 2019, 2:06am |
 |
@AmericanBanking DBV TECHNOLOGIE/S $DBVT Receives Average Rating of “Hold” from Analysts https://t.co/9MM8A9Xtre #stocks June 11th 2019, 2:06am |
 |
@ConsumerFeed -$0.68 EPS Expected for DBV TECHNOLOGIE/S $DBVT This Quarter https://t.co/DD3EWj3Inr June 10th 2019, 12:06pm |
|
@SwingTradeBot Recent $DBVT technical alerts: Fell Below 20 DMA plus 12 more alerts... https://t.co/jBMxhHFfB3 June 8th 2019, 9:06am |
 |
@TheMarketsDaily -$0.68 EPS Expected for DBV TECHNOLOGIE/S $DBVT This Quarter https://t.co/gytB6yd14M June 8th 2019, 5:06am |
 |
@dakotafinancial Zacks: Brokerages Expect DBV TECHNOLOGIE/S $DBVT to Post -$0.68 Earnings Per Share https://t.co/2uiHkmxP98 June 5th 2019, 6:06pm |
|
@AmericanBanking -$0.68 Earnings Per Share Expected for DBV TECHNOLOGIE/S $DBVT This Quarter https://t.co/rV3xy4j9yg #stocks June 5th 2019, 6:06pm |
|
@ConsumerFeed Reviewing Adaptimmune Therapeutics $ADAP & DBV TECHNOLOGIE/S $DBVT https://t.co/kHnEJWWTOP June 4th 2019, 6:06pm |
 |
@bihan35 RT @portefeuillefun: $AIMT $DBVT. New Data from Phase 3 PALISADE Follow-on Study of #AR101 for Peanut Allergy Show Continued Immunomodulati… June 4th 2019, 7:06am |
 |
@portefeuillefun $AIMT $DBVT. New Data from Phase 3 PALISADE Follow-on Study of #AR101 for Peanut Allergy Show Continued Immunomodul… https://t.co/A5X3Cz5GMG June 4th 2019, 7:06am |
 |
@confcalltran Report of foreign issuer [Rules 13a-16 and 15d-16] https://t.co/cGd4SSz1jz $DBVT June 3rd 2019, 4:06pm |
 |
@Stock_News_Now $DBVT: New SEC Filing for DBVT: Form 6-K (No. 0001193125-19-163521): https://t.co/5NXKCok9af June 3rd 2019, 9:06am |
 |
@1MinuteStock Wondering about risks of $DBVT? The 63-day volatility is 26.19% https://t.co/bSXXNqW6KL June 3rd 2019, 5:06am |
|
@1MinuteStock Do you know that #WallStreet price for $DBVT is $19.3 https://t.co/lUlbP3t8v4 June 3rd 2019, 4:06am |
 |
@biotechradar_eu $DBV Technologies $DBVT to Attend Upcoming Investor Conferences https://t.co/FiG7lTskO3 June 3rd 2019, 2:06am |
 |
@NewsToDesk $DBVT: DBV Technologies to Attend Upcoming Investor Conferences: https://t.co/v0neb5nHm2 June 3rd 2019, 1:06am |
|
@manu1r0 DBV Technologies to Present Data from Epicutaneous Immunotherapy at EAACI 2019 https://t.co/9BdCSdmgX4 $DBVT June 2nd 2019, 1:06pm |
 |
@HottestStockNow $DBVT to reveal findings for epicutaneous immunotherapy, the basis for its Viaskin technology platform https://t.co/Pe9imiKGbk June 1st 2019, 8:06pm |
|
@1MinuteStock Wondering about #sentiment indicator for $DBVT? The Short Ratio is 8.83% https://t.co/BUYXXmYd61 June 1st 2019, 11:06am |
|
@portefeuillefun RT @biotechradar_eu: $DBV Technologies $DBVT to Present Data from Epicutaneous Immunotherapy at EAACI 2019 https://t.co/cqMV5ajU3h June 1st 2019, 8:06am |
|
@biotechradar_eu $DBV Technologies $DBVT to Present Data from Epicutaneous Immunotherapy at EAACI 2019 https://t.co/cqMV5ajU3h June 1st 2019, 8:06am |
 |
@AnkurBanerjee17 RT @bio_clouseau: ICER evidence report on peanut allergy tx https://t.co/5DCgDhdx9R $AIMT $DBVT May 29th 2019, 9:05am |
 |
@bio_clouseau ICER evidence report on peanut allergy tx https://t.co/5DCgDhdx9R $AIMT $DBVT May 29th 2019, 8:05am |
|
@1MinuteStock Wondering about risks of $DBVT? The 21-day volatility is 12.83% https://t.co/bSXXNqW6KL May 27th 2019, 4:05am |
 |
@MLTherapeutics ICER released draft report on $DBVT and $AIMT clinical effectiveness and value in treating #peanutallergy (if appro… https://t.co/8giGQjWz3U May 26th 2019, 8:05am |
|
@HottestStockNow $DBVT Makes Strategic Move https://t.co/Pe9imiKGbk May 25th 2019, 4:05pm |
 |
@dailypoliticaln DBV TECHNOLOGIE/S $DBVT Rating Increased to Hold at BidaskClub https://t.co/X8p0WYPMFn May 25th 2019, 7:05am |
 |
@macondailynews DBV TECHNOLOGIE/S $DBVT Given Average Rating of “Hold” by Analysts https://t.co/oXOXA7nj0L May 24th 2019, 7:05pm |
|
@Stock_News_Now $DBVT: New SEC Filing for DBVT: Form 6-K (No. 0001193125-19-157095): https://t.co/T9vUd88chN May 24th 2019, 4:05pm |
|
@WatchlistN DBV TECHNOLOGIE/S $DBVT – Investment Analysts’ Weekly Ratings Changes https://t.co/dW835iuEfl May 24th 2019, 9:05am |
|
@1MinuteStock Unicorn Bay rating for $DBVT is 2.02 out of 5. https://t.co/V4GkRX3k2K May 23rd 2019, 3:05am |
|
@ConsumerFeed DBV TECHNOLOGIE/S $DBVT Upgraded to Hold at BidaskClub https://t.co/Z3ApKp8uF1 May 23rd 2019, 2:05am |
|
@dakotafinancial DBV TECHNOLOGIE/S $DBVT Receives Average Rating of “Hold” from Brokerages https://t.co/vWCSOtuMf3 May 22nd 2019, 12:05pm |
 |
@WKRBNews Zacks: Brokerages Expect DBV TECHNOLOGIE/S $DBVT to Announce -$0.68 Earnings Per Share https://t.co/9zlOfMjsC4 #markets May 22nd 2019, 12:05am |
 |
@ZolmaxNews Aptose Biosciences $APTO & DBV TECHNOLOGIE/S $DBVT Head to Head Survey https://t.co/JBkhDxBjjm May 21st 2019, 6:05am |
 |
@WeekHerald DBV TECHNOLOGIE/S $DBVT Receives $13.04 Average Price Target from Brokerages https://t.co/OmtqZQcP6o May 20th 2019, 6:05pm |
|
@dailypoliticaln DBV TECHNOLOGIE/S $DBVT Expected to Post Earnings of -$0.68 Per Share https://t.co/EHDiz6RI7t May 19th 2019, 11:05pm |
|
@WKRBNews Critical Comparison: Aptose Biosciences $APTO & DBV TECHNOLOGIE/S $DBVT https://t.co/Io1vzp3iQS #markets May 19th 2019, 4:05am |
 |
@bulletin_en bluebird bio Inc. $DBVT Comparison side by side https://t.co/jCU4qutEMv May 18th 2019, 4:05am |
|
@WatchlistN -$0.68 EPS Expected for DBV TECHNOLOGIE/S $DBVT This Quarter https://t.co/c5n3nV6zWP May 17th 2019, 11:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.